BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11158757)

  • 1. Influence of prior exposure to zidovudine on stavudine phosphorylation in vivo and ex vivo.
    Hoggard PG; Sales SD; Phiboonbanakit D; Lloyd J; Maher BA; Khoo SH; Wilkins E; Carey P; Hart CA; Back DJ
    Antimicrob Agents Chemother; 2001 Feb; 45(2):577-82. PubMed ID: 11158757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients.
    Meléndez M; Blanco R; Delgado W; García R; Santana J; García H; Rosario O; Rodríguez JF
    Antimicrob Agents Chemother; 2006 Mar; 50(3):835-40. PubMed ID: 16495240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens.
    Ross L; Henry K; Paar D; Salvato P; Shaefer M; Fisher R; Liao Q; St Clair M
    J Hum Virol; 2001; 4(4):217-22. PubMed ID: 11694850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro.
    Hoggard PG; Sales SD; Kewn S; Sunderland D; Khoo SH; Hart CA; Back DJ
    Antivir Chem Chemother; 2000 Nov; 11(6):353-8. PubMed ID: 11227992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
    Moore JD; Valette G; Darque A; Zhou XJ; Sommadossi JP
    J Am Soc Mass Spectrom; 2000 Dec; 11(12):1134-43. PubMed ID: 11118121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients.
    Becher F; Pruvost AG; Schlemmer DD; Créminon CA; Goujard CM; Delfraissy JF; Benech HC; Grassi JJ
    AIDS; 2003 Mar; 17(4):555-61. PubMed ID: 12598776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intracellular zidovudine and its phosphorylated anabolites in the absence and presence of stavudine using an in vitro human peripheral blood mononuclear cell (PBMC) model.
    Brody SR; Aweeka FT
    Int J Antimicrob Agents; 1997 Sep; 9(2):131-5. PubMed ID: 18611830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protease inhibitors on nucleoside analogue phosphorylation in vitro.
    Hoggard PG; Manion V; Barry MG; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):164-7. PubMed ID: 9491831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
    Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
    J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.
    Hoggard PG; Kewn S; Barry MG; Khoo SH; Back DJ
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1231-6. PubMed ID: 9174176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients.
    Gilleece Y; Torti C; Mandalia S; Gazzard BG; Pillay D; Pozniak AL
    HIV Med; 2003 Oct; 4(4):305-10. PubMed ID: 14525540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients.
    Gallant JE; Chaisson RE; Keruly JC; Moore RD
    AIDS; 1999 Feb; 13(2):225-9. PubMed ID: 10202828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.
    Slusher JT; Kuwahara SK; Hamzeh FM; Lewis LD; Kornhauser DM; Lietman PS
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2473-7. PubMed ID: 1489190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine monophosphate: efficient intracellular delivery of d4TMP.
    Balzarini J; Aquaro S; Knispel T; Rampazzo C; Bianchi V; Perno CF; De Clercq E; Meier C
    Mol Pharmacol; 2000 Nov; 58(5):928-35. PubMed ID: 11040039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine.
    Gao WY; Johns DG; Tanaka M; Mitsuya H
    Mol Pharmacol; 1999 Mar; 55(3):535-40. PubMed ID: 10051538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
    Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
    J Med Virol; 1999 Dec; 59(4):507-11. PubMed ID: 10534734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.
    Winston A; McAllister J; Amin J; Cooper DA; Carr A
    HIV Med; 2005 May; 6(3):191-7. PubMed ID: 15876286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy.
    Ross L; Johnson M; Graham N; Shaefer M; St Clair M
    J Hum Virol; 1999; 2(5):290-5. PubMed ID: 10551735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral-blood mononuclear cells using high-performance liquid chromatography/tandem mass spectrometry.
    Becher F; Pruvost A; Goujard C; Guerreiro C; Delfraissy JF; Grassi J; Benech H
    Rapid Commun Mass Spectrom; 2002; 16(6):555-65. PubMed ID: 11870893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine phosphorylation and mitochondrial toxicity in vitro.
    Sales SD; Hoggard PG; Sunderland D; Khoo S; Hart CA; Back DJ
    Toxicol Appl Pharmacol; 2001 Nov; 177(1):54-8. PubMed ID: 11708900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.